💸 The Tape

Canada's most diversified cannabis and liquor conglomerate reported Q1 2026 results that reflect a company navigating genuine market headwinds while leaning heavily on its balance sheet as a strategic differentiator. Net revenue came in at $195.9 million, down 4.4% from the same period last year, with declines across all operating segments. Gross profit fell 6.8% to $52.8 million, and free cash flow was negative $7.6 million. The quarter was, by CEO Zach George's own admission, "particularly challenging."

But here's the thing about SNDL: the company is sitting on $213.4 million in unrestricted cash with zero debt as of March 31, and a total equity position of $623.6 million in cash, marketable securities, and investments. In an industry where balance sheet stress has become the norm, SNDL's financial position remains an outlier — and management clearly intends to use it.

The Segment Picture

The softness was broad-based, but not uniform.

Liquor Retail — SNDL's largest segment by revenue — posted $104.1 million in net revenue, down 4.9% year-over-year. Same-store sales declined 6.1%, reflecting persistent demand softness in Alberta's private liquor market. Gross margins improved slightly to 25.6%, helped by increased penetration of private-label offerings at accretive margins and cost optimization efforts. But the top-line decline was enough to push operating losses to $3.2 million, compared to a $2.4 million loss a year ago.

Cannabis Retail held up better, with $77.3 million in net revenue — essentially flat year-over-year. Same-store sales dipped 2.5%, partially offset by new store openings and Value Buds conversions, including the integration of five Cost Cannabis locations in Alberta and Saskatchewan. Gross margins expanded a full percentage point to 26.3%, driven by price increases, improved promotional effectiveness, and better product mix management. The segment remained operating income positive at $1.1 million, though one-time charges weighed on the bottom line.

Cannabis Operations was the weak spot. Revenue fell 14.2% to $29.4 million, driven by softening market demand, destocking activity, and disrupted business-to-business order phasing. Gross margins compressed sharply — from 26.8% to 19.7% — largely due to inventory adjustments and under-absorption from lower production volumes. One-time charges, including a write-down on the idle Stellarton facility, added further pressure. The segment's adjusted operating loss more than doubled to negative $6.9 million.

The one bright spot within Cannabis Operations: international sales doubled from $1.8 million to $3.5 million year-over-year. It's a small number in the context of SNDL's total revenue, but the growth trajectory mirrors the international momentum being captured by peers like Decibel and Organigram.

The Investments Portfolio

SNDL's investments segment — anchored by its $395.4 million position in SunStream Bancorp — generated $2 million in operating income during the quarter, primarily from interest earned on cash holdings. The carrying value of the portfolio increased $12.5 million during the quarter, driven largely by USD/CAD exchange rate movements.

The two major restructuring situations within SunStream continue to inch toward resolution. The Parallel restructuring advanced after Florida approved the license transfer in early 2025 and a final litigation settlement was reached in December. SNDL expects the strict foreclosure process to close in Q3 2026. The Skymint situation remains more uncertain — the Michigan Supreme Court has agreed to hear oral arguments but has not reached a decision on the merits.

Management flagged last week's federal rescheduling order as directly relevant to the investments portfolio. The move of state-licensed medical cannabis to Schedule III — and the broader hearing on full rescheduling beginning June 29 — is expected to eliminate 280E tax burdens, improve access to capital, and strengthen the industry outlook. For SNDL, which holds significant U.S. exposure through SunStream's credit positions, the rescheduling could meaningfully improve the recovery prospects of its American cannabis investments.

Strategic Initiatives

Despite the top-line challenges, SNDL advanced several strategic priorities during the quarter. The company assumed exclusive Canadian production and commercialization of Jeeter, a leading U.S. cannabis brand, ahead of its official April 2026 launch. The Jeeter partnership positions SNDL in the premium pre-roll category — one of the fastest-growing segments in Canadian cannabis — with a brand that carries significant consumer recognition.

Management also outlined profit-enhancement initiatives expected to contribute approximately $20 million in incremental operating income over the remainder of 2026. That's a substantial figure relative to the company's current operating losses and suggests management is actively cutting costs and adjusting commercial execution rather than waiting for market conditions to improve.

On the capital return front, SNDL repurchased 4.5 million shares for cancellation during Q1, bringing total repurchases since Q4 2024 to 15.1 million shares. The board has renewed the buyback program, and management signaled continued willingness to deploy capital opportunistically.

The Outlook

George's commentary struck a balance between acknowledging current difficulties and positioning for the second half. He noted that the company anticipates improvement in the cannabis market later in the year while "proactively adjusting commercial execution and cost structure to reflect the reality of current market conditions."

The implicit message: SNDL isn't waiting for the market to rescue it. The $20 million profit-enhancement target, the Jeeter launch, continued international growth, and the approaching resolution of major U.S. investment restructurings all represent levers the company is actively pulling.

The Bottom Line

SNDL's Q1 was objectively soft. Revenue declined, margins compressed, and cash flow turned negative. In isolation, those are concerning trends for any business.

But context matters. SNDL operates from a position of financial strength that virtually no other cannabis company can match — $213 million in cash, no debt, and a diversified portfolio spanning Canadian retail, cannabis operations, and U.S. investments. In an industry where federal rescheduling is accelerating, market consolidation is inevitable, and distressed assets are becoming available at attractive prices, having a loaded balance sheet and operational discipline isn't just a nice-to-have — it's a competitive weapon.

The quarter was challenging. The positioning for what comes next is not.

📈 Dog Walkers

$VEXTF ( ▲ 9.59% ) Market Focus Is Clear

The U.S. cannabis operator reported fiscal 2025 results showing revenue of $51.4 million, up 43% year-over-year, with operating cash flow surging 256% to $11.7 million. Adjusted EBITDA came in at $10.9 million, and the company generated positive cash flow across all four quarters — a consistency that matters in an industry where many operators still struggle to get above the line.

The growth story is anchored in Ohio, where Vext expanded its retail footprint from two to five dispensaries during the year, with most locations performing above the state average. The company holds a path to the state dispensary cap of eight locations by early 2027, positioning it to capture sustained growth from Ohio's expanding adult-use market. A seventh dispensary license in Columbus was granted in March 2026, with buildout underway.

On the Arizona side, Vext is taking a different approach — pulling back. The company announced plans to exit cultivation at its Eloy facility and pursue a sale of the property, transitioning to a lean, retail-first model focused on its high-performing Phoenix dispensaries. The move is designed to reduce debt, free up capital, and redeploy resources toward Ohio's higher-return opportunities.

CEO Eric Offenberger framed it as disciplined capital allocation: "By refocusing on our high-performing Phoenix dispensaries and redeploying that capital into our Ohio expansion, we are aligning the business around our highest-return opportunities."

Q4 revenue of $13.7 million was up 35% year-over-year, though reported EBITDA was impacted by a $5 million non-cash impairment on one Columbus location. Management expects margins to improve as newer Ohio stores ramp and the retail base stabilizes.

🗞️ The News

📺 YouTube

How TerrAscend is Preparing for Rescheduling | TTB Presented by Flowhub

What we will cover:

✅ In our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell sit down with leadership from TerrAscend (TSX:TSND) to break down Q1 2026 preliminary earnings and what’s actually happening under the hood.

Chairman Jason Wild and CEO Ziad Ghanem join us to walk through the numbers following their preliminary Q1 release.

Revenue came in around $65.5M—slightly down quarter-over-quarter, but back to year-over-year growth. Margins? Still holding strong north of 52%. And maybe most important—this marks another quarter of positive operating cash flow in what continues to be a tough pricing environment across key markets like New Jersey.